Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Cytosorbents Corp
| Metric | Cytosorbents Corp CTSOHealthcare |
|---|---|
| Quality Score | 43 / 100 |
| Revenue (latest) | $37M |
| Net income (latest) | −$8M |
| Operating margin | −39.8% |
| Net margin | −22.1% |
| Return on equity | −138.9% |
| Return on assets | −18.6% |
| Return on capital (ROCE) | −42.8% |
| Debt / equity | 6.48× |
| Revenue growth (YoY) | 4.1% |
| Altman Z″ (distress) | -23.50 |
| Accruals / assets | 9.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.